Clover Health Investments, Corp.
CLOV
$3.66
$0.205.78%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.51% | -7.81% | |||
| Total Other Revenue | -25.26% | 32.19% | |||
| Total Revenue | 1.81% | -7.09% | |||
| Cost of Revenue | -2.69% | 0.57% | |||
| Gross Profit | 15.65% | -24.74% | |||
| SG&A Expenses | 27.53% | -9.73% | |||
| Depreciation & Amortization | 1.47% | 2.73% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.32% | -2.38% | |||
| Operating Income | -130.05% | -221.71% | |||
| Income Before Tax | -144.52% | -222.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -144.52% | -222.52% | |||
| Earnings from Discontinued Operations | -65.14% | -255.46% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -141.31% | -223.58% | |||
| EBIT | -130.05% | -221.71% | |||
| EBITDA | -134.91% | -212.44% | |||
| EPS Basic | -140.11% | -223.03% | |||
| Normalized Basic EPS | -129.41% | -221.43% | |||
| EPS Diluted | -119.23% | -298.10% | |||
| Normalized Diluted EPS | -129.41% | -223.96% | |||
| Average Basic Shares Outstanding | 0.34% | 0.55% | |||
| Average Diluted Shares Outstanding | 0.34% | -1.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
